Investment
Features
FeesSafety
Academy
More
Pluang+

NETSOL Technologies posts record Q4 revenue, forecasts strong growth for fiscal 2027.

Company Fundamentals
01 Oct 2026
Alex Lavoie
View Source
Bullish
NETSOL Technologies posts record Q4 revenue, forecasts strong growth for fiscal 2027.

NETSOL Technologies reported a record $20.7 million revenue in fiscal 2026 Q4, with net income rising 45.9% to $3.8 million. The company improved its gross margin to 63.6% and operating margin to 21.6%, reflecting enhanced profitability. For fiscal 2027, NETSOL forecasts revenue growth of 13-16% and adjusted EBITDA growth of 15-25%, signaling continued strong performance. The stock has gained over 32% in the past month, outperforming the market ahead of its Q1 2027 earnings report due October 5, 2026.

NETSOL Technologies' upcoming Q1 2027 earnings preview provides context for technology sector performance. For readers following technology stocks, here is Pluang's market snapshot as of Oct 02, 2026 03:31 WIB: out of 150 priced US technology stocks, 118 rose and 31 fell today. Notable movers include CDNS at USD 351.22 with a 6.37% increase and a typical hold time of 74 days, HUBS at USD 217.77 up 6.28% with a 77-day hold time, and TEAM at USD 190.00 rising 5.97% with a 64-day hold time.

More News

Analysts rate BlackRock stock 'Overweight' ahead of strong Q3 earnings forecast.

Analysts rate BlackRock stock 'Overweight' ahead of strong Q3 earnings forecast.

Wells Fargo initiated coverage on BlackRock with an 'Overweight' rating, highlighting it as a good entry point for investors. Analysts expect BlackRock's Q3 earnings per share to rise to $14.25 from $11.55 a year ago, with revenue projected at $7.56 ...

Analyst Insights
Bullish
58 minutes ago
Nike misses revenue targets and issues weak outlook due to China market challenges, shares fall 5.8%.

Nike misses revenue targets and issues weak outlook due to China market challenges, shares fall 5.8%.

Nike reported earnings per share of $0.48, beating estimates, but revenue fell short at $11.21 billion due to weak demand in Greater China and rising competition. The company issued a cautious fiscal 2027 outlook with EPS forecast between $1.15 and $...

Company Fundamentals
Bearish
1 hour ago
Nexalin, Armada, Roze AI, Mattel, and Accenture lead market gains on key deals and earnings beats

Nexalin, Armada, Roze AI, Mattel, and Accenture lead market gains on key deals and earnings beats

On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...

Market News
Bullish
1 hour ago
Jefferies sets $150 target for Nektar Therapeutics amid promising alopecia drug data despite stock drop.

Jefferies sets $150 target for Nektar Therapeutics amid promising alopecia drug data despite stock drop.

Jefferies analyst Roger Song set a $150 price target for Nektar Therapeutics, suggesting a 219% upside from its $46.99 trading price. This comes after Nektar presented positive six-month Phase IIb trial results for its alopecia drug REZPEG, which als...

Analyst Insights
Bullish
1 hour ago
Boeing shares rise as new union contract secures 737 production and avoids strike risk.

Boeing shares rise as new union contract secures 737 production and avoids strike risk.

Boeing's stock rose following the approval of a new four-year union contract covering 13,000 engineers and 4,000 technical workers. The agreement prevents a potential strike that could have disrupted 737 production and delayed aircraft deliveries, pr...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App